• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

17/01/2026 16:24

Mangalam Drugs - Announcement under Regulation 30 (LODR)-Change in Management

Disclosure Pursuant to Regulation 30, Schedule III, Part A, Para 7(B) of SEBI(LODR) Regulations, 2015 for resignation of Mr. Rukmesh P. Dhandhania -Independent Director of the Company.